3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
13
Urinary Bladder Neoplasms
12
Neoplasms
10
Carcinoma, Renal Cell
9
Ovarian Neoplasms
7
Carcinoma, Transitional Cell
7
Neoplasm Metastasis
6
Pancreatic Neoplasms
5
Breast Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Carcinoma, Merkel Cell
4
Triple Negative Breast Neoplasms
3
Recurrence
3
Lymphoma
3
Lung Neoplasms
3
Fallopian Tube Neoplasms
3
Colorectal Neoplasms
3
Stomach Neoplasms
2
Prostatic Neoplasms
2
Melanoma
2
Leukemia, Myeloid, Acute
2
Kidney Neoplasms
2
Kidney Diseases
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Hepatocellular
2
Urothelial Cancer
1
Urologic Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Turcot syndrome
1
Interventions
Paclitaxel
9
Carboplatin
6
Cisplatin
5
Hyperthermic Intraperitoneal Chemotherapy
4
Oxaliplatin
3
Fluorouracil
3
Cytoreduction Surgical Procedures
3
Bevacizumab
3
nintedanib
2
Mitomycin
2
Leucovorin
2
Laparoscopy
2
Gemcitabine
2
Folfox protocol
2
Docetaxel
2
vandetanib
1
talimogene laherparepvec
1
strattice
1
sodium thiosulfate
1
poly(I).poly(c12,U)
1
pembrolizumab
1
olaparib
1
nilotinib
1
liposomal doxorubicin
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
farletuzumab
1
enzastaurin
1
catumaxomab
1
birinapant
1
atezolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Peritoneal Neoplasms
×
avelumab
×
Clear all
No trials found.